Blood flow modification in the sccvii tumor: Effects of 5-Hydroxytryptamine, hydralazine, and propanolol
- 31 December 1992
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 22 (3), 463-465
- https://doi.org/10.1016/0360-3016(92)90854-b
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Relationship between the hydralazine-induced changes in murine tumor blood supply and mouse blood pressureInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Drug induced perturbations in tumor blood flow: therapeutic potential and possible limitationsRadiotherapy and Oncology, 1991
- The effects of oral hydralazine on blood pressure, cardiac output and peripheral resistance with respect to dose, age and acetylator statusRadiotherapy and Oncology, 1990
- Histological evidence for nonperfused vasculature in a murine tumor following hydralazine administrationInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Winner of the 1988 Lund Science Award: Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinomain vivoInternational Journal of Hyperthermia, 1989
- The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069: Evidence for therapeutic gainInternational Journal of Radiation Oncology*Biology*Physics, 1987
- Potentiation of RSU-1069 tumour cytotoxicity by 5-hydroxytryptamine (5-HT)British Journal of Cancer, 1986
- Cell selection from a murine tumour using the fluorescent probe Hoechst 33342British Journal of Cancer, 1985